Application of NFκB inhibitor for arthritis

Japanese Journal of Clinical Immunology

Volumn 32, Issue 2, 2009, Pages 71-76

  Tomita, Tetsuya ^a   Kunugiza, Yasuo ^a   Nomura, Koji ^a   Morimoto, Daiki ^a   Kuroda, Shoko ^a   Yoshikawa, Hideki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Decoy oligodeoxynucleotides; NF B; Parthenolide; Rheumatoid arthritis; Transcriptional factor

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CYTOKINE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METALLOPROTEINASE; PARTHENOLIDE;

ARTHRITIS; CELL STIMULATION; CIS ISOMER; COLLAGEN INDUCED ARTHRITIS; CYTOKINE PRODUCTION; DRUG STRUCTURE; DRUG TARGETING; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PHARMACOLOGICAL BLOCKING; REVIEW; RHEUMATOID ARTHRITIS; STRUCTURE ACTIVITY RELATION; SYNOVIOCYTE; TANACETUM PARTHENIUM; TRANSCRIPTION REGULATION; ANIMAL; DRUG ANTAGONISM; GENE THERAPY; HAPLORHINI; METHODOLOGY; RAT;

ANIMALS; ARTHRITIS, RHEUMATOID; GENE THERAPY; HAPLORHINI; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; RATS;

EID: 68849109723     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.32.71     Document Type: Review

References (18)

1. Criscione LG, St Clair EW.: Tumor necrosis factor-alpha antagonists for the treatment of rheumatic diseases. Curr Opin Rheumatol. 14(3): 204-211, 2002.
2. Taylor PC.: Anti-cytokines and Cytokines in the Treatment of Rheumatoid Arthritis. Curr Pharm Des. 9(14): 1095-1106, 2003.
3. Bathon J, Martin RW, Fleishman RM, et al.: A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis. N Engl J Med. 343(22): 1586-1593, 2000.
4. Elliott MJ, Maini RN, Feldmann M, et al.: Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor Arthritis Rheum 36: 1681-1690, 1993.
5. Bresnihan B, Cunnane G.: Infection complications associated with the use of biologic agents. Rheum Dis Clin North Am. 29(1): 185-202, 2003.
6. Sen R, Baltimore D.: Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell. 47(6): 921-928, 1986.
7. Collart MA, Baeuetie PA, Vassalli P.: Regulation of tumor necrosis, factor alpha transcription in macrophages: involvement of four kB-like motifs and constitutive and inducible form of NFkB. Mol Cell Biol 10: 1498-1506,
8. Fujisawa K, et al.: Activation of transcriptional factor NFkB in human synovial cells in response to tumor necrosis factor a. Arthritis Rheum 39: 197-203, 1996.
9. Handel ML, McMorrow LB, Gravallese EM.: Nuclear factor-κB in rheumatoid synovium. Localization of p50 and p65. Arthritis Rheum 38: 1762-1770, 1995.
10. Williams RO, Feldmann M, Maini RN.: Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci USA 89: 9784-9788, 1992.
11. Marok R, Winyard PG, Coumbe A, et al.: Activation of the transcription factor nuclear factor-kB in human inflamed synovial tissue. Arthritis Rheum 39: 583-591, 1996.
12. Morishita R, et al.: In vivo transfection of cis element "decoy" against nuclear factor kB binding site prevents myocardial infarction. Nat Med 3: 894-899, 1997.
13. Tomita N, Morishita R, Tomita T, Ogihara T.: Potential therapeutic application of decoy oligonucleotides. Curr Opin Mol Ther. 4: 166-170, 2002.
14. Tomita T, Hashimoto H, Tomita N, et al.: In vivo direct gene transfer into articular cartilage by intraarticular injection mediated by HVJ (Sendai virus) and liposomes. Arthritis Rheum 40: 901-906, 1997.
15. Tomita T, Takano H, Tomita N, et al.:4 Transcription factor decoy for NFkB inhibits cytokine and adhesion molecule expression in synovial cells derived from rheumatoid arthritis. Rheumatology 39: 749-757, 2000.
16. Tomita N, Tomita T, Yuyama K, et al.: Development of novel decoy oligonucleotides: advantages of circular dumb-bell decoy. Curr Opin Mol Ther 5: 107-112, 2003.
17. Kunugiza Y, Tomita T, Tomita N, et. Al.: Inhibitory effect of ribbon-type NF-kappaB decoy oligodeoxynucleotides on osteoclast induction and activity invitro and in vivo. Arthritis Res Ther 8: R103, 2006.
18. Kishida Y, Yoshikawa H, Myoui A.: Parthenolide, a natural inhibitor of nuclear factor-kB, inhibits lung colonization of murine osteosarcoma cells. Clin Cancer Res 13: 59-67, 2007.